Suppr超能文献

子宫颈癌患者的血清铜作为放射治疗成功的指标

Serum copper in carcinoma of cervix uteri as an indicator of successful radiotherapy.

作者信息

Birdi A, Gupta S, Gambhir S S

出版信息

J Surg Oncol. 1983 Mar;22(3):193-6. doi: 10.1002/jso.2930220313.

Abstract

Serum copper levels (SCL) have been done in 106 patients of squamous cell carcinoma of the cervix and in 15 cases of local recurrences. The mean SCL has been significantly elevated in them in comparison to controls (P less than 0.001). The SCL falls to near normal range following successful therapy. There is a trend to elevation in SCL as the disease progresses. Mean SCL is unrelated to the various morphologic types of squamous cell carcinoma. SCL when compared with clinical radiation response (CRR) show that good CRR has highest mean difference of pre- and posttreatment value in comparison to moderate and poor CRR. It appears that highest SCL is associated with advanced disease and poorest prognosis. The estimation of SCL can be used as a check parameter of recurrence and as a prognostic tool in the management of carcinoma of the cervix uteri.

摘要

对106例子宫颈鳞状细胞癌患者及15例局部复发患者进行了血清铜水平(SCL)检测。与对照组相比,他们的平均SCL显著升高(P<0.001)。成功治疗后SCL降至接近正常范围。随着疾病进展,SCL有升高趋势。平均SCL与鳞状细胞癌的各种形态学类型无关。将SCL与临床放射反应(CRR)比较显示,与中度和差的CRR相比,良好的CRR在治疗前后值的平均差异最高。似乎最高的SCL与晚期疾病和最差的预后相关。SCL的检测可作为子宫颈癌复发的检查参数和预后工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验